▲ 2.42%
prev close
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Congressional Trades
4
All tracked trades
Members Trading
4
Unique members
Net Activity
-4
0 buys · 4 sells
Members Who Traded This Stock
4 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-08-05 | ALCAlcon Inc. Ordinary Shares | Sell | $1,001 - $15,000 | 49d ago | — | |
| 2026-03-12 | ALCAlcon Inc. Ordinary Shares | Sell | $1,001 - $15,000 | 195d ago | — | |
| 2025-03-03 | ALCAlcon Inc. Ordinary Shares | Sell | $1,001 - $15,000 | 554d ago | — | |
| 2023-07-10 | ALCAlcon Inc. Ordinary Shares | Sell | $15,001 - $50,000 | 1164d ago | — |
2026-08-05
Kevin Hern
ALC
Amount
$1,001 - $15,000
Filed
49d ago
2026-03-12
Josh Gottheimer
ALC
Amount
$1,001 - $15,000
Filed
195d ago
2025-03-03
Julie Johnson
ALC
Amount
$1,001 - $15,000
Filed
554d ago
2023-07-10
Daniel Goldman
ALC
Amount
$15,001 - $50,000
Filed
1164d ago
Recent News
Powered by Polygon.io
Wellcome Leap Appoints John Young and Thomas Glanzmann to Board of Directors
Bill Ackman’s Pershing Square Just Bought Netflix and 5 Other Stocks. Here’s What Investors Need to Know.
Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?
National Advertising Division Finds Certain ACUVUE® Oasys Max Claim Supported; Recommends Modification or Discontinuation of Others
Trade Timeline
Congressional activity, newest first
Kevin Hern
2026-08-05 · Sale
$1,001 - $15,000
Josh Gottheimer
2026-03-12 · Sale
$1,001 - $15,000
Julie Johnson
2025-03-03 · Sale
$1,001 - $15,000
Daniel Goldman
2023-07-10 · Sale
$15,001 - $50,000